USAntibiotics reopens Tennessee production facility
After previously going bankrupt, center is now under US ownership for the first time
USAntibiotics, the American manufacturer of penicillin-based amoxicillin and amoxil clavulanate, the antibiotics known as Amoxil and Augmentin, reopened its 360,000 square-foot, Bristol, TN manufacturing facility, which had slipped into bankruptcy and stopped operations last year. The latest news marks the first time the facility is under US ownership, formerly being owned by China.
Once the facility comes online, the company says that it will have the ability to produce 300 million capsules and two billion tablets a year, and will be able manufacture and stockpile a five-year supply of amoxicillin for the US.
" … Our mission is to solve our nation's reliance on foreign Amoxicillin and create a secure stockpile that will stand the test of time,” notes Rick Jackson, founder, CEO, and chairman of Jackson Healthcare, which purchased the Bristol facility from bankruptcy earlier this year.
